United-guardian Inc (UG)

$9.0901

-0.06

(-0.67%)▲

Market is closed - opens 7 PM, 23 May 2024

Insights on United-guardian Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 2.60M → 3.25M (in $), with an average increase of 19.9% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, 461.09K → 925.44K (in $), with an average increase of 20.6% per quarter

  • Vs CL

    In the last 1 year, Colgate-palmolive Co. has given 21.4% return, outperforming this stock by 17.4%

  • Vs PG

    In the last 3 years, Procter & Gamble Company, The has given 13.0% return, outperforming this stock by 59.3%

Performance

  • $9.09
    $9.28
    $9.09
    downward going graph

    0.0%

    Downside

    Day's Volatility :1.99%

    Upside

    1.99%

    downward going graph
  • $5.46
    $9.43
    $9.09
    downward going graph

    39.93%

    Downside

    52 Weeks Volatility :42.1%

    Upside

    3.61%

    downward going graph

Returns

PeriodUnited-guardian IncIndex (Russel 2000)
3 Months
12.01%
0.0%
6 Months
17.32%
0.0%
1 Year
3.99%
0.0%
3 Years
-48.3%
-20.1%

Highlights

Market Capitalization
42.0M
Book Value
$2.48
Dividend Share
0.35
Dividend Yield
4.14%
Earnings Per Share (EPS)
0.56
PE Ratio
16.34
PEG Ratio
0.0
Profit Margin
23.72%
Operating Margin TTM
30.35%
Return On Assets TTM
15.19%
Return On Equity TTM
25.0%
Revenue TTM
10.9M
Revenue Per Share TTM
2.37
Quarterly Revenue Growth YOY
-5.6000000000000005%
Gross Profit TTM
6.7M
EBITDA
3.0M
Diluted Eps TTM
0.56
Quarterly Earnings Growth YOY
0.09
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Company Financials

FY18Y/Y Change
Revenue
13.8M
↑ 6.18%
Net Income
4.4M
↑ 13.22%
Net Profit Margin
31.61%
↑ 1.97%
FY19Y/Y Change
Revenue
13.6M
↓ 1.24%
Net Income
4.8M
↑ 9.41%
Net Profit Margin
35.01%
↑ 3.4%
FY20Y/Y Change
Revenue
11.0M
↓ 19.21%
Net Income
3.3M
↓ 30.59%
Net Profit Margin
30.08%
↓ 4.93%
FY21Y/Y Change
Revenue
13.9M
↑ 26.79%
Net Income
4.7M
↑ 40.96%
Net Profit Margin
33.44%
↑ 3.36%
FY22Y/Y Change
Revenue
12.7M
↓ 8.84%
Net Income
2.6M
↓ 44.84%
Net Profit Margin
20.23%
↓ 13.21%
FY23Y/Y Change
Revenue
10.9M
↓ 14.28%
Net Income
2.6M
↑ 0.46%
Net Profit Margin
23.71%
↑ 3.48%
Q4 FY22Q/Q Change
Revenue
2.8M
↑ 14.31%
Net Income
679.2K
↑ 96.58%
Net Profit Margin
24.58%
↑ 10.28%
Q1 FY23Q/Q Change
Revenue
2.6M
↓ 6.97%
Net Income
756.1K
↑ 11.32%
Net Profit Margin
29.42%
↑ 4.84%
Q2 FY23Q/Q Change
Revenue
2.7M
↑ 3.11%
Net Income
461.1K
↓ 39.02%
Net Profit Margin
17.4%
↓ 12.02%
Q3 FY23Q/Q Change
Revenue
3.1M
↑ 15.37%
Net Income
626.8K
↑ 35.93%
Net Profit Margin
20.5%
↑ 3.1%
Q4 FY23Q/Q Change
Revenue
2.6M
↓ 14.73%
Net Income
737.4K
↑ 17.66%
Net Profit Margin
28.29%
↑ 7.79%
Q1 FY24Q/Q Change
Revenue
3.3M
↑ 24.85%
Net Income
925.4K
↑ 25.49%
Net Profit Margin
28.43%
↑ 0.14%
FY18Y/Y Change
Total Assets
12.5M
↓ 2.4%
Total Liabilities
1.6M
↑ 11.23%
FY19Y/Y Change
Total Assets
12.4M
↓ 1.45%
Total Liabilities
1.7M
↑ 6.8%
FY20Y/Y Change
Total Assets
11.9M
↓ 3.58%
Total Liabilities
1.6M
↓ 9.48%
FY21Y/Y Change
Total Assets
12.2M
↑ 2.7%
Total Liabilities
2.4M
↑ 54.6%
FY22Y/Y Change
Total Assets
10.6M
↓ 13.09%
Total Liabilities
1.4M
↓ 43.26%
FY23Y/Y Change
Total Assets
13.4M
↑ 25.55%
Total Liabilities
2.0M
↑ 43.41%
Q4 FY22Q/Q Change
Total Assets
10.6M
↓ 8.87%
Total Liabilities
1.4M
↓ 17.46%
Q1 FY23Q/Q Change
Total Assets
11.9M
↑ 12.22%
Total Liabilities
1.9M
↑ 39.6%
Q2 FY23Q/Q Change
Total Assets
11.9M
↓ 0.53%
Total Liabilities
1.4M
↓ 27.33%
Q3 FY23Q/Q Change
Total Assets
12.2M
↑ 2.49%
Total Liabilities
1.5M
↑ 9.19%
Q4 FY23Q/Q Change
Total Assets
13.4M
↑ 9.74%
Total Liabilities
2.0M
↑ 29.46%
Q1 FY24Q/Q Change
Total Assets
13.0M
↓ 2.33%
Total Liabilities
1.9M
↓ 4.47%
FY18Y/Y Change
Operating Cash Flow
5.0M
↑ 24.0%
Investing Cash Flow
-308.8K
↓ 110.97%
Financing Cash Flow
-4.8M
↓ 25.99%
FY19Y/Y Change
Operating Cash Flow
4.5M
↓ 9.58%
Investing Cash Flow
1.1M
↓ 447.19%
Financing Cash Flow
-5.0M
↑ 4.85%
FY20Y/Y Change
Operating Cash Flow
3.6M
↓ 19.7%
Investing Cash Flow
-468.7K
↓ 143.72%
Financing Cash Flow
-3.6M
↓ 29.06%
FY21Y/Y Change
Operating Cash Flow
5.3M
↑ 47.83%
Investing Cash Flow
-183.5K
↓ 60.85%
Financing Cash Flow
-5.2M
↑ 44.87%
FY22Y/Y Change
Operating Cash Flow
2.5M
↓ 52.47%
Investing Cash Flow
897.6K
↓ 589.2%
Financing Cash Flow
-3.1M
↓ 39.82%
Q4 FY22Q/Q Change
Operating Cash Flow
624.7K
↓ 15.1%
Investing Cash Flow
1.1M
↓ 290.5%
Financing Cash Flow
-1.4M
↑ 0.0%
Q1 FY23Q/Q Change
Operating Cash Flow
417.6K
↓ 33.16%
Investing Cash Flow
-46.1K
↓ 104.07%
Financing Cash Flow
0.0
↓ 100.0%
Q2 FY23Q/Q Change
Operating Cash Flow
434.7K
↑ 4.09%
Investing Cash Flow
4.8M
↓ 10615.31%
Financing Cash Flow
0.0
-

Technicals Summary

Sell

Neutral

Buy

United-guardian Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
United-guardian Inc
United-guardian Inc
12.56%
17.32%
3.99%
-48.3%
-54.02%
Colgate-palmolive Co.
Colgate-palmolive Co.
7.74%
23.15%
21.37%
12.76%
33.05%
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
-9.97%
8.23%
-32.96%
-56.12%
-20.8%
Procter & Gamble Company, The
Procter & Gamble Company, The
4.86%
11.48%
12.87%
22.03%
57.75%
Kenvue Inc.
Kenvue Inc.
1.99%
-0.35%
-23.4%
-25.76%
-25.76%
Kimberly-clark Corp.
Kimberly-clark Corp.
3.73%
9.34%
-4.95%
1.23%
2.11%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
United-guardian Inc
United-guardian Inc
16.34
16.34
0.0
0.0
0.25
0.15
0.04
2.48
Colgate-palmolive Co.
Colgate-palmolive Co.
29.97
29.97
2.15
3.53
0.53
0.16
0.02
0.28
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
73.67
73.67
1.6
2.24
0.1
0.03
0.02
16.02
Procter & Gamble Company, The
Procter & Gamble Company, The
27.33
27.33
3.28
6.55
0.32
0.11
0.02
20.87
Kenvue Inc.
Kenvue Inc.
25.5
25.5
2.11
1.13
0.1
0.06
0.04
5.55
Kimberly-clark Corp.
Kimberly-clark Corp.
24.49
24.49
1.57
7.12
1.81
0.11
0.04
3.1
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
United-guardian Inc
United-guardian Inc
NA
$42.0M
-54.02%
16.34
23.72%
Colgate-palmolive Co.
Colgate-palmolive Co.
Buy
$77.4B
33.05%
29.97
13.22%
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
Buy
$47.0B
-20.8%
73.67
4.18%
Procter & Gamble Company, The
Procter & Gamble Company, The
Buy
$397.3B
57.75%
27.33
17.99%
Kenvue Inc.
Kenvue Inc.
Buy
$38.1B
-25.76%
25.5
9.63%
Kimberly-clark Corp.
Kimberly-clark Corp.
Hold
$45.0B
2.11%
24.49
9.05%

Institutional Holdings

  • Renaissance Technologies Corp

    4.00%

  • Gamco Investors, Inc. Et Al

    3.40%

  • Vanguard Group Inc

    2.90%

  • Rodgers Brothers Inc.

    2.08%

  • Dimensional Fund Advisors, Inc.

    1.85%

  • Teton Advisors Inc

    1.47%

Company Information

the company performs research and development in the areas of cosmetic ingredients, medical products, pharmaceuticals, and industrial products. we have been in business since 1942, and sell our products through a global network of marketing partners to most ot the global cosmetic companies. the most important product line is an extensive line of water-based moisturizing and lubricating gels, which have both cosmetic and medical applications.

Organization
United-guardian Inc
Employees
23
CEO
Ms. Donna Vigilante
Industry
Consumer Non-Durables

Discover More

FAQs